CLINICAL_TRIALS
trial_result
· 2014-08-13
Clinical Trial Update: A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis [Phase 2]
Summary
Biogen completed a Phase 2 study of interferon beta-1a (Avonex) in active ulcerative colitis, with trial results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Active Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2014-08-13